Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089186507> ?p ?o ?g. }
- W3089186507 endingPage "E26" @default.
- W3089186507 startingPage "E13" @default.
- W3089186507 abstract "ABSTRACT BACKGROUND A sustained release microparticle formulation of nimodipine (EG-1962) was developed for treatment of patients with aneurysmal subarachnoid hemorrhage (aSAH). OBJECTIVE To assess safety, tolerability, and pharmacokinetics of intracisternal EG-1962 in an open-label, randomized, phase 2 study of up to 12 subjects. METHODS Subjects were World Federation of Neurological Surgeons grades 1 to 2, modified Fisher grades 2 to 4, and underwent aneurysm clipping within 48 h of aSAH. EG-1962, containing 600 mg nimodipine, was administered into the basal cisterns. Outcome on the extended Glasgow Outcome Scale (eGOS), pharmacokinetics, delayed cerebral ischemia and infarction, rescue therapy, and safety were evaluated. RESULTS The study was halted when a phase 3 study of intraventricular EG-1962 stopped because that study was unlikely to meet its primary endpoint. Six subjects were randomized (5 EG-1962 and 1 oral nimodipine). After 90-d follow-up, favorable outcome on the eGOS occurred in 1 of 5 EG-1962 and in the single oral nimodipine patient. Four EG-1962 and the oral nimodipine subject had angiographic vasospasm. One EG-1962 subject had delayed cerebral ischemia, and all subjects with angiographic vasospasm received rescue therapy except 1 EG-1962 patient. One subject treated with EG-1962 developed right internal carotid and middle cerebral artery narrowing 5 mo after placement of EG-1962, leading to occlusion and cerebral infarction. Pharmacokinetics showed similar plasma concentrations of nimodipine in both groups. CONCLUSION Angiographic vasospasm and unfavorable clinical outcome still occurred after placement of EG-1962. Internal carotid artery narrowing and occlusion after placement of EG-1962 in the basal cisterns has not been reported." @default.
- W3089186507 created "2020-10-01" @default.
- W3089186507 creator A5000156377 @default.
- W3089186507 creator A5000492857 @default.
- W3089186507 creator A5001908694 @default.
- W3089186507 creator A5006362128 @default.
- W3089186507 creator A5019068952 @default.
- W3089186507 creator A5031709626 @default.
- W3089186507 creator A5038958115 @default.
- W3089186507 creator A5048916190 @default.
- W3089186507 creator A5049222047 @default.
- W3089186507 creator A5052946442 @default.
- W3089186507 creator A5062595802 @default.
- W3089186507 creator A5068022071 @default.
- W3089186507 creator A5072272174 @default.
- W3089186507 creator A5078165592 @default.
- W3089186507 creator A5090506665 @default.
- W3089186507 date "2020-09-28" @default.
- W3089186507 modified "2023-10-13" @default.
- W3089186507 title "NEWTON-2 Cisternal (Nimodipine Microparticles to Enhance Recovery While Reducing Toxicity After Subarachnoid Hemorrhage): A Phase 2, Multicenter, Randomized, Open-Label Safety Study of Intracisternal EG-1962 in Aneurysmal Subarachnoid Hemorrhage" @default.
- W3089186507 cites W1966109927 @default.
- W3089186507 cites W1972491904 @default.
- W3089186507 cites W1973695633 @default.
- W3089186507 cites W1974016081 @default.
- W3089186507 cites W1974485973 @default.
- W3089186507 cites W1974622414 @default.
- W3089186507 cites W1981079502 @default.
- W3089186507 cites W1981605115 @default.
- W3089186507 cites W1987731530 @default.
- W3089186507 cites W1992813877 @default.
- W3089186507 cites W20077224 @default.
- W3089186507 cites W2011644803 @default.
- W3089186507 cites W2015140911 @default.
- W3089186507 cites W2016174231 @default.
- W3089186507 cites W2017396797 @default.
- W3089186507 cites W2025171812 @default.
- W3089186507 cites W2028417000 @default.
- W3089186507 cites W2033585094 @default.
- W3089186507 cites W2034370745 @default.
- W3089186507 cites W2047403952 @default.
- W3089186507 cites W2052213175 @default.
- W3089186507 cites W2059057097 @default.
- W3089186507 cites W2067491541 @default.
- W3089186507 cites W2074370034 @default.
- W3089186507 cites W2075958633 @default.
- W3089186507 cites W2079386464 @default.
- W3089186507 cites W2103764744 @default.
- W3089186507 cites W2105812737 @default.
- W3089186507 cites W2141204523 @default.
- W3089186507 cites W2144456462 @default.
- W3089186507 cites W2157006832 @default.
- W3089186507 cites W2163353654 @default.
- W3089186507 cites W2165758561 @default.
- W3089186507 cites W2289349361 @default.
- W3089186507 cites W2296117242 @default.
- W3089186507 cites W2560508979 @default.
- W3089186507 cites W2883260430 @default.
- W3089186507 cites W2911931732 @default.
- W3089186507 cites W2912476192 @default.
- W3089186507 cites W2945807354 @default.
- W3089186507 cites W2969066858 @default.
- W3089186507 cites W3005303323 @default.
- W3089186507 cites W3011205514 @default.
- W3089186507 cites W4236805817 @default.
- W3089186507 cites W4247979151 @default.
- W3089186507 cites W4293240757 @default.
- W3089186507 doi "https://doi.org/10.1093/neuros/nyaa430" @default.
- W3089186507 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32985652" @default.
- W3089186507 hasPublicationYear "2020" @default.
- W3089186507 type Work @default.
- W3089186507 sameAs 3089186507 @default.
- W3089186507 citedByCount "7" @default.
- W3089186507 countsByYear W30891865072022 @default.
- W3089186507 countsByYear W30891865072023 @default.
- W3089186507 crossrefType "journal-article" @default.
- W3089186507 hasAuthorship W3089186507A5000156377 @default.
- W3089186507 hasAuthorship W3089186507A5000492857 @default.
- W3089186507 hasAuthorship W3089186507A5001908694 @default.
- W3089186507 hasAuthorship W3089186507A5006362128 @default.
- W3089186507 hasAuthorship W3089186507A5019068952 @default.
- W3089186507 hasAuthorship W3089186507A5031709626 @default.
- W3089186507 hasAuthorship W3089186507A5038958115 @default.
- W3089186507 hasAuthorship W3089186507A5048916190 @default.
- W3089186507 hasAuthorship W3089186507A5049222047 @default.
- W3089186507 hasAuthorship W3089186507A5052946442 @default.
- W3089186507 hasAuthorship W3089186507A5062595802 @default.
- W3089186507 hasAuthorship W3089186507A5068022071 @default.
- W3089186507 hasAuthorship W3089186507A5072272174 @default.
- W3089186507 hasAuthorship W3089186507A5078165592 @default.
- W3089186507 hasAuthorship W3089186507A5090506665 @default.
- W3089186507 hasBestOaLocation W30891865071 @default.
- W3089186507 hasConcept C126322002 @default.
- W3089186507 hasConcept C141071460 @default.
- W3089186507 hasConcept C197934379 @default.
- W3089186507 hasConcept C2776820941 @default.
- W3089186507 hasConcept C2777294900 @default.
- W3089186507 hasConcept C2777736543 @default.
- W3089186507 hasConcept C2778333808 @default.